DTcP Booster is a vaccine being developed by us that
addresses the weaker protection preventing pertussis
after primary vaccination, designed for children
(4 to 6 years old). We are developing a potential China
first-in-class DTcP booster vaccine to address the lack
of vaccines that protect against pertussis after primaryvaccination of co-purified DTaP vaccines. Our DTcP booster candidate received CTA approval in 2018. We have commenced a phase I clinical trial, which we expect to complete in 2019.
Copyright © ( 2017) CanSino Biologics Inc
For the record: 津ICP备14006666号-2